106.92 +0.01 (0.01%)
After hours: 4:44PM EDT
|Bid||104.95 x 100|
|Ask||107.55 x 100|
|Day's Range||106.44 - 109.09|
|52 Week Range||17.33 - 111.36|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 7, 2018 - May 11, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||91.57|
Why Are Investors Excited about Nektar Therapeutics in 2018? Nektar Therapeutics (NKTR) generates revenues from collaboration agreements through which it receives product sales revenues, royalties, license fees, milestone payments, and contract research payments. In fiscal 2017, Nektar Therapeutics generated total revenues of $307.7 million compared with $165.4 million in fiscal 2016.
Why Are Investors Excited about Nektar Therapeutics in 2018? Nektar Therapeutics (NKTR) is a biopharmaceutical company with investigational drug candidates for the treatment of cancer, autoimmune disease, and chronic pain. Of the nine analysts covering Nektar Therapeutics in March 2018, four of them have given the stock a “strong buy” rating.
Take-Two Interactive Software Inc., SVB Financial Group and Nektar Therapeutics are joining the S&P 500 index, according to S&P Dow Jones Indices.
NEW YORK , March 9, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents ...
SAN FRANCISCO , March 7, 2018 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) Senior Vice President and Chief Scientific Officer, Jonathan Zalevsky , Ph.D., is scheduled to present at the upcoming ...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
NEW YORK, NY / ACCESSWIRE / March 5, 2018 / Shares of Nektar Therapeutics and Zosano Pharma both blew up in Friday trading. Nektar saw big gains after reporting better than expected fourth quarter results ...
A small-capitalization healthcare sector ETF climbed Friday after Nektar Therapeutics (NasdaqGS: NKTR) and ICU Medical (NasdaqGS: ICUI) posted their fourth quarter results. The PowerShares S&P SmallCap ...